Back to search
FDAFDA · Food and drugs·Recall number D-0363-2026

Max Packaging Antibacterial Towelette (Benzalkonium Chloride 0.13%), 1 towelette, 4x7, Max Packaging, Made in the USA, NDC 59647-750-01

Published March 11, 2026 · Recall initiated: January 20, 2026

Summary

FDA records drug Class II recall D-0363-2026, published March 11, 2026 and initiated January 20, 2026. Recalling firm: ACME UNITED CORPORATION; Status: Ongoing; Reported quantity: N/A; Lot: Lot #: MN24523, Exp. Date July 2028; MN27123, Exp. Date Aug 2028; MN28223, Exp. Date Sep 2028. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

CGMP Deviations

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
ACME UNITED CORPORATION
Distributor
Nationwide within the United States
Lot
Lot #: MN24523, Exp. Date July 2028; MN27123, Exp. Date Aug 2028; MN28223, Exp. Date Sep 2028.
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Max Packaging Antibacterial Towelette (Benzalkonium Chloride 0.13%), 1 towelette, 4x7, Max Packaging, Made in the USA, NDC 59647-750-01 recalled?

Yes. FDA published recall D-0363-2026 on March 11, 2026. Reported hazard: CGMP Deviations

What should I do if I have this product?

Voluntary: Firm initiated · Letter